EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Patient‐Controlled Sedation in Port Implantation ( PACSPI 2)—A Randomised Clinical Trial

Stefanie Seifert iD, Knut Taxbro, Andreas Nilsson iD, Josip Azman, Michelle S Chew, Fredrik Hammarskjöld

Acta Anaesthesiologica Scandinavica · 2026

DOI: 10.1111/aas.70148 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2026. Verfasst von Stefanie Seifert und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia and Intensive Care Medicine, Ryhov County Hospital, Jönköping, Sweden. Hauptthemen laut MEDLINE: Analgesia, Patient-Controlled, Vascular Access Devices. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Futurum - Akademin för Hälsa och Vård, Region Jönköpings läns.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Optimising pain management during subcutaneous venous port (SVP) implantation is essential for patient‐centred cancer care. However, evidence‐based approaches to minimise intraoperative pain remain underexplored. This trial evaluated the clinical effectiveness and safety of the propofol‐alfentanil patient‐controlled sedation (PCS) technique as an adjunct to local anaesthesia (LA) for pain reduction during SVP implantation. Adult cancer patients at two Swedish anaesthesia departments received either LA + PCS or LA alone for SVP implantation. The primary outcome was the maximum intraoperative pain score on an 11‐point numeric rating scale (NRS). Safety outcomes included respiratory, haemodynamic and insertion‐related complications. Secondary outcomes assessed patient satisfaction and procedural measurements. A total of 340 patients (median age 70 [interquartile range, [IQR] 61–76], 51.8% male) were recruited between January 2023 and November 2024. Median intraoperative NRS pain scores were similar between groups (2 [0–3] vs. 2 [0–3], p = 0.292), with pain scores ≥ 4 reported in 22.9% (LA + PCS) and 22.2% (LA) (OR 0.96; 95% CI 0.57–1.60; p = 0.872). Hypoxia or obstructed airway occurred in 2/166 (1.2%) patients in the LA + PCS group and none in the LA group. Patient satisfaction was high in both groups (10 [10–10], p = 0.102). Optimal procedural conditions were reported more frequently with LA + PCS (96.4% vs. 82.0%; OR 5.84; 95% CI 2.36–14.44; p < 0.001), without affecting perioperative workflow. Propofol‐alfentanil PCS does not significantly reduce intraoperative pain in patients during SVP implantation. Its routine use for pain reduction cannot be recommended. However, PCS may reasonably be offered to patients who prefer procedural sedation. Editorial Comment This randomised clinical trial found that adding patient‐controlled sedation with propofol‐alfentanil to standard local anaesthesia for subcutaneous venous port implantation does not have an impact on pain scores or patient satisfaction. Additional studies focusing on patients experiences and safety are recommended before implementing propofol‐alfentanil patient‐controlled sedation. Trial Registration: EudraCT number: 2021‐003821‐31; ClinicalTrials.gov identifier: NCT 05688384.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesia, Patient-ControlledVascular Access DevicesHumansMaleFemaleAgedMiddle AgedPropofolAlfentanilPatient SatisfactionAnesthesia, LocalPain MeasurementPain ManagementProcedural Sedation

Stichwörter der Autor:innen

PCSTIVADanalgosedationcentral venous catheter insertionpain scorepatient‐controlled sedationsubcutaneous venous port implantation

Substanzen

PropofolAlfentanil

Autor:innen und Institutionen

  • Department of Anaesthesia and Intensive Care Medicine, Ryhov County Hospital, Jönköping, Sweden.
  • Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Department of Anaesthesia and Intensive Care, Linköping University Hospital, Linköping, Sweden.
  • Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
  • Pain and Rehabilitation Department, Linköping University Hospital, Linköping, Sweden.
  • Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Stefanie Seifert, Andreas Nilsson

Förderung

  • Futurum - Akademin för Hälsa och Vård, Region Jönköpings läns

Zitieren

APA

Seifert, S., Taxbro, K., Nilsson, A., Azman, J., Chew, M. S., & Hammarskjöld, F. (2026). Patient‐Controlled Sedation in Port Implantation ( PACSPI 2)—A Randomised Clinical Trial. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.70148

Vancouver

Seifert S, Taxbro K, Nilsson A, Azman J, Chew MS, Hammarskjöld F. Patient‐Controlled Sedation in Port Implantation ( PACSPI 2)—A Randomised Clinical Trial. Acta Anaesthesiologica Scandinavica. 2026. doi:10.1111/aas.70148

BibTeX
@article{Seifert2026,
  author = {Seifert, Stefanie and Taxbro, Knut and Nilsson, Andreas and Azman, Josip and Chew, Michelle S and Hammarskjöld, Fredrik},
  title = {Patient‐Controlled Sedation in Port Implantation ( PACSPI 2)—A Randomised Clinical Trial},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2026},
  doi = {10.1111/aas.70148}
}
Kostenlos starten →